Lancashire and South Cumbria
Formulary
 
back
13 Skin

This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net. 

For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/

13-06-02 Hormone treatment for acne

Co-Cyprindiol
Formulary
Tablets cyproterone 2mg / ethinylestradiol 35 micrograms

CSM advice: VTE risk - see BNF
Link  MHRA: Cyproterone acetate with ethinylestradiol (co-cyprindiol): balance of benefits and risks remains positive

Green View adult BNF  View SPC online  View childrens BNF